Amylin Pharmaceuticals

From Wikipedia, the free encyclopedia

Amylin Pharmaceuticals
Type Public (NASDAQAMLN)
Founded 1987
Headquarters San Diego, California
Industry Biotechnology
Products Symlin (pramlintide)
Byetta (exenatide)
Employees 1550 [1]
Website http://amylin.com/

Amylin Pharmaceuticals is a biopharmaceutical company based in San Diego, CA, that was founded in 1987. Currently, Amylin produces two drugs, Symlin (pramlintide acetate) and Byetta (exenatide). Amylin also is working on producing a drug based on Leptin.[2] Amylin is part of the NASDAQ-100.

Languages